Journal of Shandong University (Health Sciences) ›› 2022, Vol. 60 ›› Issue (9): 85-90.doi: 10.6040/j.issn.1671-7554.0.2022.0368

Previous Articles     Next Articles

Sensitivity of GPCR-G protein fusion sensor to detect the interaction between GPCR and G protein

MA Chuanshun1,2, LIN Hui2, SUN Jinpeng1,2, ZHANG Daolai1   

  1. 1. School of Pharmacy, Binzhou Medical University, Yantai 264003, Shandong, China;
    2. Department of Basic Medical Sciences, Shandong University, Jinan 250012, Shandong, China
  • Published:2022-09-02

PDF (PC)

74

Abstract: Objective GPR56-G protein fusion sensor was used as a prototype to establish a highly sensitive method to detect the interaction between GPCR and G protein. Methods The N-terminus of the G protein α subunit with NanoLuc luciferase(Nluc)was fused to the C-terminus of the GPCR. The fusion protein of both GPCR and G protein α subunit was constructed as the experimental group, and the receptor and G protein were co-expressed as a control group. The constitutive activity of GPR56-Gα12 subunit fusion protein, GPR56 and Gα12 subunit co-expression were compared with bioluminescence resonance energy transfer(BRET)at the same level of receptor expression. The effect of agonist(P19)on the interaction of GPR56-Gα12 subunit fusion protein was detected with BRET. Results The BRET ratio results showed that the GPR56-Gα12 subunit fusion protein had stronger constitutive activity than the control group co-expressed with GPR56 and Gα12 subunits(F=424.7, P<0.001). Compared with the control group, the experimental group had decreased half effective concentration(EC50)of P19 activation (t=13.36, P<0.001). The GPR56-Gα12 subunit fusion protein was more sensitive to P19 and had a stronger affinity. Conclusion The GPCR-Gα subunit fusion protein system is a sensitive method to detect the interaction between GPCRs and G protein.

Key words: GPCR-Gα subunit fusion protein, GPR56, Gα12, Constitutive activity, P19

CLC Number: 

  • Q5-33
[1] Qin K, Dong C, Wu G, et al. Inactive-state preassembly of G(q)-coupled receptors and G(q)heterotrimers[J]. Nat Chem Biol, 2011, 7(10): 740-747.
[2] Smith JS, Lefkowitz RJ, Rajagopal S. Biased signalling: from simple switches to allosteric microprocessors[J]. Nat Rev Drug Discov, 2018, 17(4): 243-260.
[3] Santos R, Ursu O, Gaulton A, et al. A comprehensive map of molecular drug targets[J]. Nat Rev Drug Discov, 2017, 16(1): 19-34.
[4] Hauser AS, Chavali S, Masuho I, et al. Pharmacogenomics of GPCR drug targets[J]. Cell, 2018, 172(1-2): 41-54 e19.
[5] Cheng J, Yang Z, Ge XY, et al. Autonomous sensing of the insulin peptide by an olfactory G protein-coupled receptor modulates glucose metabolism[J]. Cell Metab, 2022, 34(2): 240-255. e10.
[6] Ghislain J, Poitout V. Targeting lipid GPCRs to treat type 2 diabetes mellitus—progress and challenges[J]. Nat Rev Endocrinol, 2021, 17(3): 162-175.
[7] Bjarnadottir TK, Fredriksson R, Hoglund PJ, et al. The human and mouse repertoire of the adhesion family of G-protein-coupled receptors[J]. Genomics, 2004, 84(1): 23-33.
[8] Dorsam RT, Gutkind JS. G-protein-coupled receptors and cancer[J]. Nat Rev Cancer, 2007, 7(2): 79-94.
[9] Gales C, Rebois RV, Hogue M, et al. Real-time monitoring of receptor and G-protein interactions in living cells[J]. Nat Methods, 2005, 2(3): 177-184.
[10] Gales C, Van Durm JJ, Schaak S, et al. Probing the activation-promoted structural rearrangements in preassembled receptor-G protein complexes[J]. Nat Struct Mol Biol, 2006, 13(9): 778-786.
[11] Hein P, Frank M, Hoffmann C, et al. Dynamics of receptor/G protein coupling in living cells[J]. EMBO J, 2005, 24(23): 4106-4114.
[12] Lohse MJ, Nuber S, Hoffmann C. Fluorescence/bioluminescence resonance energy transfer techniques to study G-protein-coupled receptor activation and signaling[J]. Pharmacol Rev, 2012, 64(2): 299-336.
[13] Sriram K, Insel PA. G Protein-coupled receptors as targets for approved drugs: how many targets and how many drugs?[J]. Mol Pharmacol, 2018, 93(4): 251-258.
[14] Civelli O, Reinscheid RK, Zhang Y, et al. G protein-coupled receptor deorphanizations[J]. Annu Rev Pharmacol Toxicol, 2013, 53: 127-146. doi: 10.1146/annurev-pharmtox-010611-134548.
[15] Milligan G, Parenty G, Stoddart LA, et al. Novel pharmacological applications of G-protein-coupled receptor-G protein fusions[J]. Curr Opin Pharmacol, 2007, 7(5): 521-526.
[16] Bahia DS, Wise A, Fanelli F, et al. Hydrophobicity of residue351 of the G protein Gi1 alpha determines the extent of activation by the alpha 2A-adrenoceptor[J]. Biochemistry, 1998, 37(33): 11555-11562.
[17] Wise A, Sheehan M, Rees S, et al. Comparative analysis of the efficacy of A1 adenosine receptor activation of Gi/o alpha G proteins following coexpression of receptor and G protein and expression of A1 adenosine receptor-Gi/o alpha fusion proteins[J]. Biochemistry, 1999, 38(8): 2272-2278.
[18] Wan Q, Okashah N, Inoue A, et al. Mini G protein probes for active G protein-coupled receptors(GPCRs)in live cells[J]. J Biol Chem, 2018, 293(19): 7466-7473.
[19] Janetopoulos C, Jin T, Devreotes P. Receptor-mediated activation of heterotrimeric G-proteins in living cells[J]. Science, 2001, 291(5512): 2408-2411.
[20] Xerri L, Mathoulin MP, Birg F, et al. Heterogeneity of rearranged T-cell receptor V-alpha and V-beta transcripts in tumor-infiltrating lymphocytes from Hodgkins disease and non-Hodgkins lymphoma[J]. Am J Clin Pathol, 1994, 101(1): 76-80.
[21] Colquhoun D. Binding, gating, affinity and efficacy: the interpretation of structure-activity relationships for agonists and of the effects of mutating receptors[J]. Br J Pharmacol, 1998, 125(5): 924-947.
[22] Paavola KJ, Stephenson JR, Ritter SL, et al. The N terminus of the adhesion G protein-coupled receptor GPR56 controls receptor signaling activity[J]. J Biol Chem, 2011, 286(33): 28914-28921.
[23] Azimzadeh P, Talamantez-Lyburn SC, Chang KT, et al. Spatial regulation of GPR64/ADGRG2 signaling by beta-arrestins and GPCR kinases[J]. Ann N Y Acad Sci, 2019, 1456(1): 26-43.
[24] Kishore A, Purcell RH, Nassiri-Toosi Z, et al. Stalk-dependent and stalk-independent signaling by the adhesion G protein-coupled receptors GPR56(ADGRG1)and BAI1(ADGRB1)[J]. J Biol Chem, 2016, 291(7): 3385-3394.
[25] 郭芮伶. 粘附受体GPR56与肿瘤[J]. 中华肺部疾病杂志(电子版), 2015, 8(4): 482-484.
[26] Xiao P, Guo S, Wen X, et al. Tethered peptide activation mechanism of the adhesion GPCRs ADGRG2 and ADGRG4[J]. Nature, 2022, 604(7907): 771-778.
[27] Ping YQ, Xiao P, Yang F, et al. Structural basis for the tethered peptide activation of adhesion GPCRs[J]. Nature, 2022, 604(7907): 763-770.
[28] Qu X, Qiu N, Wang M, et al. Structural basis of tethered agonism of the adhesion GPCRs ADGRD1 and ADGRF1[J]. Nature, 2022, 604(7907): 779-785.
[1] ZHOU Jian, ZHAO Hanting, LÜ Gang, WANG Lin, LI Qihang, ZHU Meiyan, WANG Zhilin, HE Shenyi. Bioinformatics analysis and construction of an eukaryocyte vector of ROP19 protein in Toxoplasma gondii [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 64-69.
[2] . Expression of bHLH genes in differentiation of P19 cells [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(10): 19-22.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] MA Qingyuan, PU Peidong, HAN Fei, WANG Chao, ZHU Zhoujun, WANG Weishan, SHI Chenhui. Effect of miR-27b-3p regulating SMAD1 on osteosarcoma cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 32 -37 .
[2] SUO Dongyang, SHEN Fei, GUO Hao, LIU Lichang, YANG Huimin, YANG Xiangdong. Expression and mechanism of Tim-3 in animal model of drug-induced acute kidney injury[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 1 -6 .
[3] ZHANG Baowen, LEI Xiangli, LI Jinna, LUO Xiangjun, ZOU Rong. miR-21-5p targeted TIMP3 to inhibit proliferation and extracellular matrix accumulation of mesangial cells in Type II diabetic nephropathy mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 7 -14 .
[4] FU Jieqi, ZHANG Man, ZHANG Xiaolu, LI Hui, CHEN Hong. Molecular mechanism of Toll-like receptor 4 in the aggravation of blood lipid accumulation by inhibiting the peroxisome proliferator-activate receptor γ[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 24 -31 .
[5] LONG Tingting, XIE Ming, ZHOU Lu, ZHU Junde. Effect of Noggin protein on learning and memory abilities and the dentate gyrus structure after cerebral ischemia reperfusion injury in mice[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 15 -23 .
[6] LI Ning, LI Juan, XIE Yan, LI Peilong, WANG Yunshan, DU Lutao, WANG Chuanxin. Expression of LncRNA AL109955.1 in 80 cases of colorectal cancer and its effect on cell proliferation, migration and invasion[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 38 -46 .
[7] DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60 -66 .
[8] XU Yuxiang, LIU Yudong, ZHANG Peng, DUAN Ruisheng. A retrospective analysis of risk factors of cerebral microbleeds in 101 patients with cerebral small vessel disease[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 67 -71 .
[9] XIAO Juan, XIAO Qiang, CONG Wei, LI Ting, DING Shouluan, ZHANG Yuan, SHAO Chunchun, WU Mei, LIU Jianing, JIA Hongying. Comparison of diagnostic efficacy of two kinds of thyroid imagine reporting and data systems[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 53 -59 .
[10] SHI Shuang, LI Juan, MI Qi, WANG Yunshan, DU Lutao, WANG Chuanxin. Construction and application of a miRNAs prognostic risk assessment model of gastric cancer[J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 47 -52 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd